ImmunityBio, Inc. IBRX

Paul Silberberg your thoughts please

L Guitar sending you huge hugs

Brain BFD $9.50 whoopee how about $25 -$50 in a couple years who cares about $1

🖕 all of the shorts and penny flippers and day traders buy hold invest

Hope you are all caught out when IBRX POPS WAY HIGHER

Why the probability of meaningful integration is high:

1. Perfect strategic fit Soon-Shiong's core thesis has always been combining immune activators
   (IL-15 via Anktiva) with targeted vaccines and other cytokines. PDS0301 (tumor-targeted IL-12)

• PDSO101 (HPV vaccine) slots directly into that architecture — especially for hard-to-treat solid tumors like MSS colorectal cancer.

1. Structural incentives The second tranche of capital only drops if the Phase 3 protocol is co-designed with Nant. That almost forces real scientific collaboration.
2. PDSB's position They already stopped internal funding for PDS0101 Phase 3 and were under severe cash pressure. They need a strong partner. Soon-Shiong just became the most

👉👿🖕👿☠️

PDSB triples and no coverage by the worthless bought and paid for MSM

CNBC and FoxB suck they are Wall Street taking heads and slaves to big pharma ad $

PDSB is a very interesting company and I see why Dr PSS made an investment. It could easily be bought for 5-10 billion and IBRX could be the buyer or big pharma.

Multiple clinical trials and different cancers

Paul Silberberg where did you go best post about IBRX

Gus what shit? mRNA covid jabs. My bet you lined up like a little terrified idiot with mass hysteria